Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Adult Neuro > ALS > Flashcards

ALS Flashcards

1
Q

ALS- Definition

A

“a degenerative disease of the neuromuscular system involving both upper and lower motor neurons, resulting in weakness of the limbs, trunk, bulbar, and respiratory muscles”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ALS

  • neuropathology
  • signs/symptoms
A

neuropathology: lateral, corticospinal tracts, anterior horn cells, anterior roots and peripheral nerves, CN nuclei, corticobulbar trances
Signs and Sx: spasticity and weakness in bulbar and spinal system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pseudo-Bulbar Palsy (PBP)

  • neuropathology
  • signs/symptoms
A

Neuropathology: bulbar nuclei

Signs and Sx: flaccid weakness of bulbar muscles (swallowing and speech)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Progressive Muscular Atrophy (PMA)

  • neuropathology
  • signs/symptoms
A

Neuropathology: Ventral horn cells of spinal cord (LMN)

Signs and Sx:weakness and wasting of extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary Lateral Sclerosis (PLS)

  • neuropathology
  • signs/symptoms
A

Neuropathology: motor cells of the cortex and corticospinal tracts (UMN)
Signs and Sx: spastic weakness of trunk and extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Spinal Muscular Atrophy (SMA)

  • neuropathology
  • signs/symptoms
A

Neuropathology: primary motor eurons in anterior horn of SC and brainstem motor nuclei
Signs and Sx: weakness and wasting of extremities and bulbar muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

UMN Syndrome signs

A 
Loss of dexterity
loss of muscle strength
spasticity
hyperreflexia
pathological reflex
flexor spasms
involuntary emotional expressive disorder (IEED)- inappropriate laughing and crying
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LMN Syndrome signs

A
  1. loss of muscle strength
  2. muscle atrophy
  3. muscle hypotonia
  4. hyporeflexia
  5. fasciculations
  6. muscle cramps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Uncommon manifestations of ALS

A
  1. sensory impairments (if sensory impairment, not thinking ALS)
  2. ocular palsy (muscle of the eyes are typically spared)
  3. Bladder and bowel dysfunction
  4. Dementia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fronto-Temporal Dementia (FTD)

A

occurs in 15% of ALS patients, involves cortical atrophy

symptoms:
- word finding difficulties
- behavioral changes
- executive dysfunction
- poor judgement

  • memory is not usually impaired, screening exam with MMSE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathogenesis: 3 hypotheses

A
  1. oxidative stress and mitochondrial dysfunction causing inflammation
  2. excitotoxicity: increased levels of glutamate in CNS (kills neurons)
  3. Cell death and apoptosis (via MAP kinase activtation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnostic Testing: 3 factors

A
  1. Lower motor neuron involvement (EMG)
  2. Upper motor neuron involvement (MRI, MR Spec, TMS, clinical exam)
  3. Additional Tests to rule out everything else (lumbar puncture, muscle and nerve biopsies, blood tests)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lower Motor Neurons Testing: Expected presentation/occurance on EMG

A
  1. Denervation
  2. decreased motor units
  3. fibrillations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lower Motor Neurons Testing: Procedure of EMG

A

Needles are inserted into motor points.
Performed in the limb, tongue, paraspinals
Uncomfortable!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Upper Motor Neuron Testing: Clinical exam findings

A
  • clinical exam extremely important in UMN diagnosis

- hyperreflexia/abnormal reflexes (babinski, hoffman)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Differential Diagnoses of ALS

A
  1. Degenerative arthritis
  2. motor neuropathy
  3. inflammatory muscle disease
  4. metabolic. infectious, endocrine and electrolyte imbalance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ALS: sex ratio, age of onset, racial predisposition

A

sex ratio: 1.2-1.6:1 (M:F)
age of onset: 60s
Racial: none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Prognosis: mean survival time, 5yr survival, 10yr survival

A

Mean survival time: 27-43months (2-4yrs)
5-year survival time: 9-40% (25% mean)
10-year survival time: 8-16%

*UMN lesions tend to live longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

AAN Practice parameters: guidelines for practice in treating ALS pt

A
  1. Breaking the news
  2. symptom management
  3. nutrition management
  4. respiratory management
  5. Palliative care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Only drug that is FDA approved as treatment in ALS

A

Riluzole- extends life by 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Symptomatic Treatment: what symptoms get treated

A
  1. Muscle cramps
  2. Spasticity
  3. Sialorrhea Management (uncontrolled drooling/management of secretions)
  4. Depression
  5. Involuntary Expressive Disorder (IEED)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Muscle Cramp Treatment

A
  1. Quinine sulfate (perscription)
  2. Tonic water
  3. stretching profalactively
    * more common in LMN syndrome
23
Q

Spasticity treatment

A
  1. oral baclofen or tizanidine
  2. intrathecal baclofen pump
  3. stretching
  4. heat
  5. repetitive, light resistance exercise
    * sometimes spasticity helps with function
24
Q

Sialorrhea Management

A
  1. suction machine
  2. drugs to dry secretions (atrophine, scopolamine, cold/allergy meds, amitriptyline-antidepressant)
  3. Botox to parotid glands
  4. radiation to parotid and submandibular glands
  5. litigation of ducts of salivary glands
25
Q

Depression management

A
  1. antidepressants (Celexa, paxil, remeron)
  2. psychotherapy
  3. support groups
26
Q

Involuntary Emotional Expressive Disorder (IEED) Management

A

Nuedexta

27
Q

Nutritional Management

A
  1. maintain weight (difficult- pts have high caloric demands)
  2. high calorie diet
  3. Nutritional supplements (Ensure)
  4. Early PEG (sweet spot with timing- risky if pulmonary function is too low)
28
Q

Respiratory Treatment

A
  1. Non-invasive ventilation (NIV)
  2. Cough Assist (if weak cough)
  3. Tracheostomy- ONLY lift sustaining measure
29
Q

Non-Invasive Ventilation (NIV)

  • what does it do
  • type of ventilators
  • when is it used
A
  • decreases the work of breathing
  • volume ventilators (BiPAP- pressure controlled)
  • Used when FVC
30
Q

Tracheostomy

  • purpose
  • how many pts choose it
A
  • only life sustaining measure (but disease continues to progress)
  • long term mechanical ventilaiton
  • 2-5% choose LTMR, even though it is reversible and life sustaining
31
Q

ALS Functional Rating Scale Revised (ALSFRS-R)

  • purpose
  • predicatbility
  • administration/items
  • subcategories
  • Pro
A
  • disease specific measure of global function; correlates with changes in strength measures over time; compares function today with time prior to ALS
  • predicts survival!!!!
  • 12 item scale, questions asked by assessor
  • 4 categories: bulbar, arm, leg, respiratory function
  • easily administered
  • used in stage 2 and 3 clinical trials
32
Q

MMT v MVIC in strength assessment

A

MMT: not functionally meaninful, burdensome for pt
MVIC: used as marker for disease, but not functionally meaningful and burdensome, requires elaborate equipment and specialized training

33
Q

Timed Up and Go in ALS population

  • purpose
  • predictability
  • con
A

Tests for balance and mobility

Pedictable of falls (

34
Q

Forced Vital Capacity in ALS population

  • Purpose
  • predictability
A
  • assesses diaphragmatic strength, aids in determining timing or nutritional, respiratory, and palliative treatments
  • predicts survival

*useful in clinical trials

35
Q

Rehab goal in the ALS population

A

to maintain the highest quality of life and function

36
Q

Goals of Exercise in ALS

A
  1. improve function
  2. avoid complication of weakness
    * *NOT to rebuild muscle- maintenance is more important
37
Q

Types of Exercise for ALS rehab

A
  1. Functional (walking, transfers, balance)
  2. Aerobics (walking, bike/elliptical, aquatics)
  3. ROM
38
Q

Van der Kooi EL et. al: Exercise trials in muscle diseases from 1966-2002

A

Moderate intensity exercise shows no benefit (disease modifying) or harm

39
Q

Cup EH et al: Systematic review of exercise and/or physcial therapy intervention in neuromuscular disease

A

No adverse effects of individualized progressive strengthening protocols. Combination of strengthening and aerobic exercises is likely to be effective (the best approach)

40
Q

Lui 2009: A systematic review of exercise studies in ALS

A

Small-moderate effect sizes supporting moderate exercise in early-stage ALS. No adverse effects

41
Q

Animal model- SOD1 mice

A

moderate intensity exercise extended survival; high intensity exercise hastened onset of symptoms and decreased survival time

42
Q

Dal Bello-Haas 2007:

A
  • 5 reps at full 6RM weight, 5 reps at 75%RM weight, 5 reps at 50% of 6RM weight
  • higher ALSFRS-R and leg strength MVIC scores in exercise group at 6 months
43
Q

Kilmer 2001: Eccentric exercise

A

showed similar responses to high intensity eccentric loads in persons with slowly progressive muscular dystrophies and controls

44
Q

Aerobic/cardiovascular recommendations in ALS

A

60-80% HRmax
11-14 on BORG
30mins 5x/wk

45
Q

Pinto: studied TM exercise with NIV to assist tissue oxygenation in ALS

A

demonstrated improved respiratory function in treated group at 1 year
*note: consider inclusion (NVIC, FVC at 70%); pts more able to perform this activity

46
Q

Sanjak 2012: BWS TM training in ALS

A

improvement in 6MWT distance, ALSFRS-R, and stride length

47
Q

General guidelines for exercise

A
  1. avoid fatigue (recovery within about 1hr)
  2. avoid overworking muscles (DOMS)
  3. exercise in moderation- aerobics (Borg)
  4. low resistance strengthening (multiple reps)
  5. Stretching
  6. personalize (consider exercise hx)
  7. revisable (not static)
48
Q

Splinting and Bracing- when do we consider this?

A

When function deteriorates, assist with orthosis

i.e.- when footdrop, give them a brace. Don’t wait

49
Q

Braces of the Upper limb

A
  1. Finger extensor splint (extensors weak, prevent contractures)
  2. Hemi Shoulder Sling (straps work as deltoid, doesn’t immobilize, provides/promotes distal function)
50
Q

Neck Braces

A
  • useful due to weak neck extensors
  • soft collar
  • head master collar
  • philadelphia collar
51
Q

Considerations with DMA

A

Rollators- great to prevent falls (has a seat), not great with spasticity (slippery)

52
Q

Bulbar symptoms

A
  1. Dysarthria (difficulty swallowing)
  2. Dysphonia (can’t phonate)
  3. Dysphagia (can’t speak)
  4. Sialorrhea (uncontrolled drooling)
  5. Aspiration (liquid in lungs)
  6. Pseudobulbar symptoms/IEED
53
Q

Cranial nerves involved in speech and swallowing

A

CN V, VII, IX, X, XII

54
Q

Locked in syndrome

A

no muscle function (not even eye function) for communication

ultimately ALS pts all progress to being locked in

Adult Neuro (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions